Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
reduction decrease » reduction decreased (Expand Search), reduction reuse (Expand Search), production increases (Expand Search)
decrease risks » increased risks (Expand Search), disease risks (Expand Search), decrease rice (Expand Search)
Showing 161 - 180 results of 20,589 for search '(( significant reduction decrease ) OR ( significant decrease risks ))', query time: 0.87s Refine Results
  1. 161
    Treatment and outcome characteristics.

    Treatment and outcome characteristics. by Manik Chhabra (10822587)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  2. 162
    Forest plot of comparison of saroglitazar 4mg versus saroglitazar 2 mg on serum creatinine (mg/dL).

    Forest plot of comparison of saroglitazar 4mg versus saroglitazar 2 mg on serum creatinine (mg/dL). by Manik Chhabra (10822587)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  3. 163
    Forest plot of comparison of saroglitazar 4mg versus control on total cholesterol (mg/dL).

    Forest plot of comparison of saroglitazar 4mg versus control on total cholesterol (mg/dL). by Manik Chhabra (10822587)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  4. 164
    Forest plot of comparison of saroglitazar 4mg versus saroglitazar 2mg on LDL-cholesterol (mg/dL).

    Forest plot of comparison of saroglitazar 4mg versus saroglitazar 2mg on LDL-cholesterol (mg/dL). by Manik Chhabra (10822587)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  5. 165
    Characteristics of included studies and subjects.

    Characteristics of included studies and subjects. by Manik Chhabra (10822587)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  6. 166
    Forest plot of comparison of saroglitazar 4mg versus saroglitazar 2mg on total cholesterol (mg/dL).

    Forest plot of comparison of saroglitazar 4mg versus saroglitazar 2mg on total cholesterol (mg/dL). by Manik Chhabra (10822587)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  7. 167
    Mean absolute change results of all clinical outcomes measured in diabetes related dyslipidemia.

    Mean absolute change results of all clinical outcomes measured in diabetes related dyslipidemia. by Manik Chhabra (10822587)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  8. 168
    Cell proliferation was significantly decreased in full-length HPV16 E1 (pEGFP-E1) transfected cells.

    Cell proliferation was significantly decreased in full-length HPV16 E1 (pEGFP-E1) transfected cells. by Fern Baedyananda (11888703)

    Published 2021
    Save to List
    Saved in:
  9. 169
    Intraoperative anesthetics administered by group.

    Intraoperative anesthetics administered by group. by Adeel A. Faruki (13839691)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 170
    Fig 3 -

    Fig 3 - by Adeel A. Faruki (13839691)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  11. 171
    Postoperative outcomes.

    Postoperative outcomes. by Adeel A. Faruki (13839691)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 172
    Preoperative characteristics.

    Preoperative characteristics. by Adeel A. Faruki (13839691)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  13. 173
    Consolidated Standards of Reporting Trials (CONSORT) flow diagram.

    Consolidated Standards of Reporting Trials (CONSORT) flow diagram. by Adeel A. Faruki (13839691)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  14. 174
    Fig 2 -

    Fig 2 - by Adeel A. Faruki (13839691)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 175
    Data export.

    Data export. by Adeel A. Faruki (13839691)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  16. 176
    Flow diagram of participant selection.

    Flow diagram of participant selection. by Prajwal Paudel (7359209)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 177
    Bivariate association of characteristics of mothers (<34 weeks POG) who received and did not receive ACS.

    Bivariate association of characteristics of mothers (<34 weeks POG) who received and did not receive ACS. by Prajwal Paudel (7359209)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 178
    Supplementary file ACS.

    Supplementary file ACS. by Prajwal Paudel (7359209)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 179
    Multivariate analysis of the outcomes among the newborns who mothers receive or did not receive ACS.

    Multivariate analysis of the outcomes among the newborns who mothers receive or did not receive ACS. by Prajwal Paudel (7359209)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 180
    Bivariate analysis of morbidities among newborns whose mothers received or did not receive ACS.

    Bivariate analysis of morbidities among newborns whose mothers received or did not receive ACS. by Prajwal Paudel (7359209)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: